Chronic suppurative lung disease in a developing country: Impact on child and parent

Pediatric Pulmonology

Volumn 49, Issue 5, 2014, Pages 435-440

  Nathan, Anna Marie ^a,b   Muthusamy, Ananthan ^a   Thavagnanam, Surendran ^a   Hashim, Azfawahiza ^a   De Bruyne, Jessie ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

bronchiectasis; children; growth; Malaysia; quality of life

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; OXYGEN; SODIUM CHLORIDE; TOBACCO SMOKE;

ADENOVIRUS; ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ANTIBIOTIC PROPHYLAXIS; ANXIETY DISORDER; ARTICLE; ARTIFICIAL VENTILATION; BODY HEIGHT; BODY MASS; BODY WEIGHT; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; CHILD; CHILD GROWTH; CHILDHOOD DISEASE; CHRONIC LUNG DISEASE; CHRONIC SUPPURATIVE LUNG DISEASE; CONTROLLED STUDY; COUGHING; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; DEPRESSION; DEPRESSION ANXIETY STRESS SCALE; DEVELOPING COUNTRY; DISEASE EXACERBATION; EMOTIONAL STRESS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GROWTH CURVE; HAEMOPHILUS INFLUENZAE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INFANT; LIKERT SCALE; LUNG CYSTIC FIBROSIS; LUNG FIBROSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEASLES; MENTAL HEALTH; MYCOPLASMA PNEUMONIAE; NONHUMAN; OUTCOME ASSESSMENT; OXYGEN THERAPY; PARAINFLUENZA VIRUS INFECTION; PARENT; PATIENT COMPLIANCE; PHYSIOTHERAPY; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFLAMMATION; SPIROMETRY; SPUTUM CULTURE; SUPPURATION; TUBERCULIN TEST; TUBERCULOSIS; ANXIETY; CHILD DEVELOPMENT; COMPLICATION; COUGH; MALAYSIA; MENTAL STRESS; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PSYCHOLOGY;

ADOLESCENT; ANXIETY; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COUGH; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DEPRESSION; DEVELOPING COUNTRIES; FEMALE; HUMANS; INFANT; MALAYSIA; MALE; PARENTS; QUALITY OF LIFE; QUESTIONNAIRES; SPIROMETRY; STRESS, PSYCHOLOGICAL;

EID: 84898596467     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23001     Document Type: Article

References (26)

1. Cole PJ,. Inflammation: A two-edged sword-the model of bronchiectasis. Eur J Respir Dis Suppl 1986; 147: 6-15.
2. Chang AB, Masel JP, Boyce NC, Wheaton G, Torzillo PJ,. Non-CF bronchiectasis: Clinical and HRCT evaluation. Pediatr Pulmonol 2003; 35: 477-483.
3. Callahan CW, Redding GJ,. Bronchiectasis in children: Orphan disease or persistent problem ? Pediatr Pulmonol 2002; 33: 492-496.
4. Roberts HJ, Hubbard R,. Trends in bronchiectasis mortality in England and Wales. Respir Med 2010; 104: 981-985.
5. Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots R,. Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007. Chest 2012; 142: 432-439.
6. Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E,. Non-cystic-fibrosis bronchiectasis in children: A persisting problem in developing countries. Respiration 2005; 72: 233-238.
7. Tsao PC, Lin CY,. Clinical spectrum of bronchiectasis in children. Acta Paediatr Taiwan 2002; 43: 271-275.
8. Singleton R, Morris A, Redding G, Poll J, Holck P, Martinez P, Kruse D, Bulkow LR, Petersen KM, Lewis C,. Bronchiectasis in Alaska Native children: Causes and clinical courses. Pediatr Pulmonol 2000; 29: 182-187.
9. Chang AB, Grimwood K, Mulholland EK, Torzillo PJ,. Bronchiectasis in indigenous children in remote Australian communities. Med J Aust 2002; 177: 200-204.
10. Kapur N, Masters IB, Chang AB,. Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: What influences lung function stability ? Chest 2010; 138: 158-164.
11. Chang AB, Grimwood K, Maguire G, King PT, Morris PS, Torzillo PJ,. Management of bronchiectasis and chronic suppurative lung disease in indigenous children and adults from rural and remote Australian communities. Med J Aust 2008; 189: 386-393.
12. Rosenstein BJ, Cutting GR,. The diagnosis of cystic fibrosis: A consensus statement. J Pediatr 1998; 132: 589-595.
13. Jensen SP, Lynch DA, Brown KK, Wenzel SE, Newell JD,. High-resolution CT features of severe asthma and bronchiolitis obliterans. Clin Radiol 2002; 57: 1078-1085.
14. CDC. CDC growth charts [cited 2011 30th March]. 2009; Available from: www.cdc.gov/growthcharts/zscore.htm.
15. Royal Brompton & Harefield NHS;NHS Foundation Trust. Clinical guidelines: Care of children Cystic Fibrosis 2011. [cited 2013 20 January 2012]. Available from: www.rbht.nhs.uk/healthprofessionals/clinical-departments/ paediatrics/childrencf/
16. Newcombe PA, Sheffield JK, Juniper EF, Petsky HL, Willis C, Chang AB,. Validation of a parent-proxy quality of life questionnaire for paediatric chronic cough (PC-QOL). Thorax 2010; 65: 819-823.
17. Crawford JR, Henry JD,. The Depression Anxiety Stress Scales (DASS): Normative data and latent structure in a large non-clinical sample. Br J Clin Psychol 2003; 42: 111-131.
18. Ramli MFMA, Zain Z,. Translation, validation and psychometric properties of Bahasa Malaysia version of the Depression Anxiety and Stress Scales (DASS). ASEAN J Psychiatry 2007; 8: 82-89.
19. Newcombe PA, Sheffield JK, Chang AB,. Minimally important change in a Parent-Proxy Quality-of-Life questionnaire for pediatric chronic cough. Chest 2011; 139: 576-580.
20. Stop TB Partnership Childhood TB Subgroup. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. Chapter 1: introduction and diagnosis of tuberculosis in children. Int J Tuberc Lung Dis 2006; 10: 1091-1097.
21. Bastardo CM, Sonnappa S, Stanojevic S, Navarro A, Lopez PM, Jaffe A, Bush A,. Non-cystic fibrosis bronchiectasis in childhood: Longitudinal growth and lung function. Thorax 2009; 64: 246-251.
22. Kapur N, Masters IB, Newcombe P, Chang AB,. The burden of disease in pediatric non-cystic fibrosis bronchiectasis. Chest 2012; 141: 1018-1024.
23. Pasteur MC, Bilton D, Hill AT,. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010; 65: 577.
24. Chang AB, Grimwood K, Wilson AC, van Asperen PP, Byrnes CA, O'Grady KA, Sloots TP, Robertson CF, Torzillo PJ, McCallum GB, Masters IB, Buntain HM, Mackay IM, Ungerer J, Tuppin J, Morris PS,. Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial. Trials 2013; 14: 53.
25. Valery PC, Morris PS, Grimwood K, Torzillo PJ, Byrnes CA, Masters IB, Bauert PA, McCallum GB, Mobberly C, Chang AB,. Long term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): A multi-centre,double-blind randomised controlled trial. Lancet Respir Med 2013; 8: 610-620.
26. KA OG, Grimwood K, Cripps A, Mulholland EK, Morris P, Torzillo PJ, Wood N, Smith-Vaughan H, Revell A, Wilson A, Van Asperen P, Richmond P, Thornton R, Rablin S, Chang AB,. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial. Trials 2013; 14: 282.